NFKB1 and Miyoshi myopathy: The first study dealing with the potential use of AF to treat MM was carried out by Nakaya et al.18They selected this gold(I) compound based on its well‐known anti‐inflammatory and immunosuppressive properties through the inactivation of NF‐κB signaling.19, 27